Analysis of ultrasonically extracted interstitial fluid as a predictor of blood glucose levels. J Appl Physiol 89: 961-966, 2000.-Transdermal extraction of clinically relevant analytes offers a potentially noninvasive method of diagnostics. However, development of such a method is limited by the low permeability of skin. In this paper, we present a potential method for noninvasive diagnostics based on ultrasonic skin permeabilization and subsequent extraction of interstitial fluid (ISF) across the skin using vacuum. ISF extracted by this method was collected and analyzed for glucose and other analytes. Glucose concentration in the extracted fluid correlates well with blood glucose concentration over a range of 50-250 mg/dl. A mathematical model describing vacuum-induced transport of ISF through ultrasonically permeabilized skin is presented as well. The model accounts for convective, as well as diffusive, transport processes across blood capillaries, epidermis, and the stratum corneum. The overall predictions of the model compare favorably with the experimental observations.
DEVELOPMENT OF PAINLESS METHODS of measuring blood analyte concentrations has become an area of increasing interest, especially for the measurement of glucose (9) . A number of different technologies have been investigated using invasive, minimally invasive, and noninvasive techniques (19) . Examples of minimally invasive techniques include the use of lasers to make a small hole in the skin through which blood or interstitial fluid (ISF) can be withdrawn, lancets that penetrate only into the epidermis and extract a small sample of ISF (9) , and removal of the stratum corneum (SC), followed by extraction of ISF using vacuum (8) . Among the noninvasive techniques that have been studied, near-infrared spectroscopy has received much attention as a potential method for glucose sensing (5) . For a detailed review of blood glucose monitoring, see Ref. 19 .
Transdermal extraction of analytes offers an attractive method of noninvasive diagnostics. In this method, a sample of ISF is extracted transdermally and is subsequently analyzed for desired analytes (i.e., glucose). However, this approach is limited by the low permeability (P) of skin to glucose. The enormous barrier properties of human skin are attributed to the SC, the outermost layer of the skin (1) . A variety of approaches have been suggested to enhance transdermal transport of molecules. These include 1) the use of chemicals to modify the skin structure, 2) the application of electric fields (3, 17) , and 3) the application of ultrasound or sonophoresis (11, 13) . Although most studies of these enhancers have been performed with the objective of transdermal drug delivery, the use of iontophoresis (20) and chemical enhancers (19) has been attempted for transdermal extraction of glucose. Our laboratory has recently shown that application of ultrasound can also be used for transdermal extraction of several analytes in humans (10) . Specifically, ultrasound was used to enhance skin P and was followed by transdermal extraction of analytes using vacuum. In this paper, we present a detailed experimental and theoretical analysis of the correlation between transdermally extracted glucose and blood glucose levels.
MATERIALS AND METHODS
In vivo experiments were performed using Sprague-Dawley rats (10-16 wk of age). Rats were anesthetized with a mixture of ketamine (60 mg/kg) and xylazine (10 mg/kg), injected intraperitoneally or intramuscularly. After anesthesia was confirmed, a flanged glass cylinder (Crown Glass, diameter 15 mm, height 2 cm) was glued to the rat's shaved lateral flank using a minimal amount of cyanoacrylate adhesive (Permabond International or Vet Bond) applied to the outer edge of the flange. The chamber was filled with 2 ml of a 1% solution of sodium lauryl sulfate in phosphate-buffered saline (PBS). Ultrasound was at 20 kHz, and an intensity of 7 W/cm 2 was applied once for Ͻ1 min by immersing the horn (VCX 400, Sonics and Materials) into the liquid. The horn was positioned 1 cm above the skin inside the receiving chamber. The sonicators were operated in the pulsed mode (5-s on/5-s off, also referred to as 50% duty cycle). Ultrasound intensity was measured using a calorimetric method described elsewhere. The skin conductivity was measured between a subcutaneously inserted electrode (E242, Invivo Metric) and the metal sonicator horn. To measure the electrical resistivity of the skin, a 100-mV AC electric field (10 Hz) was applied across the skin for a short time using a signal generator (model HP 4116A). Current was measured with an ampmeter (Micronta, Tandy). The electrical resistance was then calculated from Ohm's law. The resistivity of skin was obtained by multiplying skin electrical resistance (measured experimentally) by skin area (1.7 cm 2 ). Skin conductivity was calculated by taking the reciprocal of the resistivity. Ultrasound was terminated when skin conductivity reached a value of 0.6 (k⍀-cm 2 ) Ϫ1 . At the end of sonication, the chamber contents were removed and replaced (after rinsing) with 1 ml of fresh PBS. Extraction was performed by a 15-min application of vacuum (10 in. Hg) using an Air Cadet pump (Cole-Palmer). At the end of extraction, the chamber content was collected and analyzed. Concentration of glucose (C) was measured using a Sigma assay kit (315). This kit is designed to measure physiologically relevant concentrations of analytes in serum. To increase the sensitivity of the assay, the sample-to-reagent ratio was modified to 0.4. Experiments were also performed to assess the dynamic correlation between serum C and transdermally extracted fluxes (f). In these experiments, animals were infused, via the jugular vein, with a solution of insulin (10 mU/min) to vary the blood glucose level. Extractions were performed using 5 min of vacuum (10 in. Hg) that was applied once every 20 min. Transdermal f increased with time due to structural changes in the skin and stabilized after 1 h. Transdermally extracted glucose f (measured every 20 min) collected after the 1-h stabilization period were correlated with the blood glucose values over this period, as explained in Correlation between transdermally extracted glucose and blood glucose.
RESULTS
Skin permeabilization and analyte extraction. Ultrasound-induced skin permeabilization was monitored using skin conductivity. Conductivity is an excellent indicator of skin P (15), because the lipid bilayers of the SC, which offer electrical resistance to the skin, retard transdermal transport of molecules. Conductivity of rat skin before ultrasound is ϳ0.01 (k⍀-cm 2 ) Ϫ1 . Skin conductivity increases with application of ultrasound (20 kHz, 7 W/cm 2 , 50% duty cycle). The increase in skin conductivity depends on the total energy (E) delivered to the rat skin [E ϭ I, where I is ultrasound intensity (W/cm 2 ) and is ultrasound on time in seconds (14) ]. Specifically, there exists a threshold ultrasound E (E threshold ) below which no significant change in the electrical conductivity of skin is observed. However, at energies higher than E threshold , the electrical conductivity increases with increasing ultrasound E dose. For rat skin, E threshold is ϳ1 J/cm 2 (12) . Detailed discussion of E threshold dose is provided in Refs. 12 and 15. Application of ultrasound was stopped when the conductivity achieved a value of ϳ0.6 (k⍀-cm 2 ) Ϫ1 . Although the choice of this stopping point was arbitrary, we found that skin having this conductance allowed a 100-fold enhancement of transdermal f of various analytes. Under the typical conditions used (20 kHz, 7 W/cm 2 , 50% duty cycle), the average application time required to reach the conductance was Ͻ1 min. Skin conductivity was maintained at an elevated state for the 3-h duration of the experiment. We measured transdermal glucose f through ultrasonically permeabilized skin by application of vacuum over this period. The measured glucose f was ϳ52 Ϯ 30 g ⅐ cm Ϫ2 ⅐ h Ϫ1 when the average serum C of the rat was 183 mg/dl, a f that was ϳ100 times higher than passive f across nontreated skin.
Correlation between transdermally extracted glucose and blood glucose. Because the objective of sonophoretic extraction is to correlate f values with blood glucose values, additional experiments were performed to assess the dynamic correlation between serum C and transdermally extracted f. In these experiments, rat skin was exposed to ultrasound, as described in MATE-RIALS AND METHODS. Multiple extractions were performed using vacuum (10 in. Hg for 5 min, applied every 20 min) over a period of 2 h. The first transdermal f [f 1 , nmol ⅐ cm Ϫ2 ⅐ h Ϫ1 ; after an initial 1-h stabili- zation period] was used to calculate the calibration factor [(K c ϭ B 1 /f 1 ), where B 1 is the blood glucose value (mg/dl) for each animal, measured at the same time as f 1 was extracted]. Blood glucose levels (B i ) of rats were varied by infusing insulin (Humulin, Eli Lily) intravenously at a rate of 10 mU/min for 2 h. B i were predicted, based on K c and the measured glucose f (f i ), as B i ϭ K c f i . K c ratio was calculated individually for each animal. The ratios for four animals were 0.30, 0.29, 0.13, and 0.20 mg ⅐ dl Ϫ1 ⅐ nmol Ϫ1 ⅐ cm 2 ⅐ h, respectively. The average calibration factor was 0.23 Ϯ 34%. The variability in the average K c (34%) suggests that individual calibration is necessary to achieve an accurate correlation between the glucose values predicted from transdermally extracted f and reference glucose values. This is essential because the allowed error in the predictions of blood glucose in a clinical setting is Ͻ20% (4). Figure 1 shows typical variations in blood glucose levels of a rat and the corresponding changes in transdermally extracted glucose f. Transdermally extracted glucose f correlated well with the changes in the blood glucose level in the hypo-and hyperglycemic range. Figure 2 compares the predicted blood glucose values, based on the transdermally extracted f, and those directly measured in blood. The predictions are based on a one-point calibration. The relationship between the predicted and measured glucose values is linear (r ϭ 0.97). We also assessed the relationship between transdermal glucose f and blood glucose values using an error grid (Fig. 2) . Predictions in zones A and B are clinically acceptable, whereas those outside zones A and B would lead to clinically significant errors (2) . All but 1 of the 26 predictions based on transdermal glucose f are in zones A and B. The accuracy at the low glucose levels is particularly important because the requirements of the accuracy in predictions in these regions are stricter than those at higher glucose levels. The predicted blood glucose values compare well with the measured values in this region. Another criterion for accuracy is the mean relative error between the reference and calculated glucose value defined by mean relative error {[absolute(serum glucose Ϫ calculated glucose)/serum glucose] ϫ 100}. A mean relative error of 17% was obtained for all measurements (n ϭ 26). The data presented to this point show that transdermally extracted glucose can be measured and correlates well with blood glucose values. In the next section, we present a mathematical model describing various fluid flow mechanisms that play an important role in determining the correlation between extracted f and blood glucose values.
Formulation of the mathematical model. A schematic representation of analyte transport (Q) across skin is presented in Fig. 3 . Figure 3A shows the various layers of skin involved in modeling transport during extraction, whereas Fig. 3B shows a schematic representation of various transport processes. A description of the model parameters is provided in Table 1 . The general formulation of the model is based on a model developed by Reed et al. (18) for determining transcapillary protein transport. The schematic representation ( Fig. 3) consists of four layers: capillaries, epidermal ISF (e), SC, and the receiving chamber. We assume that because the first layer of capillaries exists near the bottom of the epidermis, we may not need to account for Q across the dermis. Q of a given analyte (i.e., glucose, chosen as a model molecule) from the capillary layer into the receiving chamber is determined by a balance of various processes. Q from capillaries into the epidermis occurs through three pathways: 1) convective plasma leak, which occurs through large pores in the capillary wall and is insensitive to analyte size, 2) convective filtration, which occurs through small pores in the capillary wall and is size-selective, and 3) diffusion across the capillary wall (18) . A fraction of the amount transported from capillaries to the epidermis is recovered through convective reflux. The remaining amount is either 1) cleared by lymph, 2) transported to the SC through convection, or 3) transported to the SC through diffusion. Similarly, the amount transported into the SC is further transported to the receiving chamber through convection or diffusion. For each Q term, there is a corresponding fluid velocity (J) term, except in the case of diffusion. Each layer is characterized by an average glucose concentration (C), pressure (P), and volume (V). The capillary layer is characterized by the arterial and venous pressures. A summary of all model parameters and their typical values is provided in Table 1 . Estimation of model parameters is discussed below. Considering that the diffusive f is proportional to the C gradient and the convective f is proportional to the P gradient, this description of Q can be mathematically written as shown by Eqs. 1-15 in Table 2 (assuming steady-state conditions). The rate of accumulation of the total amount of analyte, as well as the total amount of fluid in the epidermal ISF (e) and the SC (which is equal to zero at steady state), can be described by Eqs. [16] [17] [18] [19] in Table 2 . The assumption of steady state is validated in the DISCUSSION.
Model calculations were performed using glucose as a model analyte. The objective of the model was to predict the total outflux of analyte at a given value of blood (b) C. The model includes 21 variables (listed in Table 1 ). Of these, the first 11 values in Table 1 have been independently measured by Reed et al. (18) . We calculated or measured the values of parameters 12-17 in Table 1 . Equations 1-19 were then solved simultaneously (numerically) to calculate parameters 18-21. Measurements of C b , C e , C SC , P e , P in the receiving chamber (P cham ) and the measurement of P of the SC after sonication (P SC US ) were taken as described below. 
Q, transport of analytes; J, fluid velocity; C, concentration of glucose; P, pressure; P, permeability; a, arterial; b, blood; c, convection; d, diffusion; e, epidermal ISF; f, filtration; l, lymph; pl, plasma leak; r, reflux; v, venous. C b is 183 mg/dl, which corresponds to the average C b value of the rats in our studies. Our laboratory previously measured the ISF concentrations of various analytes, including glucose (12) . These data are taken from Ref. 12 . As seen in the data from Ref. 12 , there were no statistically significant differences between the experimentally measured C b and C e under steady-state conditions. Hence C e is assumed to be the same as C b under steady-state conditions. Because the measured values of C e do not distinguish between the epidermis and SC, C SC is also assumed to be the same as C e . P e was measured in vitro. Briefly, the SC of the rat skin was removed by tape stripping (i.e., placing scotch tape on the skin and peeling the SC off layer by layer). Because tape stripping removes the SC and the next transport barrier after the SC is the epidermis, measured P of tape-stripped skin should correspond to P e . In the case of glucose, P e was ϳ0.001 cm/h. We experimentally set P cham at Ϫ25.4 mmHg. P SC US was measured experimentally by sonicating the skin and measuring glucose extraction by diffusion. In these experiments, rat skin was exposed to ultrasound using the protocol described in MATERIALS AND METHODS, and glucose was collected using passive diffusion. P SC US was found to be 3.4 ϫ 10 Ϫ3 cm/h. Comparison of model predictions with experimental data is provided in the DISCUSSION.
DISCUSSION
Application of ultrasound significantly enhanced skin P to glucose. Glucose f measured during the extraction corresponds to an ISF extraction rate of 25.6 l ⅐ cm Ϫ2 ⅐ h Ϫ1 . In this respect, it is important to note that vacuum-based extraction of ISF across tapestripped skin has been previously measured. Specifically, Kimura et al. (8) have shown that the rate of ISF extraction by application of vacuum across tapestripped skin is ϳ24 l ⅐ cm Ϫ2 ⅐ h Ϫ1 in rabbits and ϳ12 l ⅐ cm Ϫ2 ⅐ h Ϫ1 in humans (6) . The pressure used in their studies was 400 Torr. These numbers are similar to the ones we obtained. Specifically, the flow rates obtained in our experiments were ϳ25.6 and 12 l ⅐ cm Ϫ2 ⅐ h Ϫ1 in rats and humans (10), respectively. The vacuum used in our experiments was 10 in. Hg. Although the rates of ISF extraction are similar in both methods, these methods differ significantly in that 1) ultrasound does not remove SC (as revealed by histology studies) and 2) skin recovers to its baseline P relatively quickly.
Skin P measured by vacuum remained within 20% of the value observed immediately after sonication over a period of 3 h. Thus these data suggest that a short pretreatment by ultrasound permeabilizes skin rapidly and elevated skin P is maintained for at least 3 h in animals. Skin P eventually recovers due to the recovery of the skin's lipid bilayers. Specifically, we have shown that application of ultrasound enhances skin P of diabetic human volunteers and P recovers to its baseline value in 20 h (10).
Predicted glucose values based on transdermally extracted glucose compared well with those measured directly in blood (Fig. 2) . Similar results were obtained in the tests recently performed in human volunteers (10) . Specifically, ultrasound was used to permeabilize skin of human volunteers. A short application of ultrasound permeabilized skin for ϳ15 h. During this period, ISF was extracted every 30 min. C ISF was measured and compared with blood glucose values. The results showed good correlation between glucose in the ISF and in the blood. Furthermore, patients reported no pain with ultrasound application. These data demonstrate the applicability of the principles described in these studies on humans; however, further work is necessary before this method can be used in clinical applications.
We also developed a mathematical model to understand the role of various transport mechanisms in ultrasonic ISF extraction. Specifically, after the parameters from Table 1 were substituted into Eqs. 12 and 15, the predicted total outflux of glucose, at a blood glucose value of 183 mg/dl, is 38.5 g ⅐ cm Ϫ2 ⅐ h Ϫ1 . This value compares well with the experimentally measured value of 52 Ϯ 30 g ⅐ cm Ϫ2 ⅐ h Ϫ1 . Of the predicted f, ϳ90% is contributed by convection and ϳ10% by diffusion. By substituting the appropriate parameters in Eq. 11, the predicted convective fluid flow out of the SC (J ce ), is calculated to be 18 l ⅐ cm Ϫ2 ⅐ h Ϫ1 . With the assumption that the contribution of convection to the experimentally measured glucose flux is 90%, the experimental flow rate of ISF is 25.6 l ⅐ cm Ϫ2 ⅐ h Ϫ1 (based on the C ISF of 183 mg/dl and total glucose flux of 52 g ⅐ cm Ϫ2 ⅐ h Ϫ1 ). This value compares well with the predicted value of 18 l ⅐ cm Ϫ2 ⅐ h Ϫ1 .
We also evaluated the assumption of steady state by calculating the time constants (T) associated with glucose extraction. T of analyte extraction across the SC and the epidermis is approximately given by T ϭ J ce / (V SC ϩ V e ), where V SC and V e correspond, respectively, to the volumes of the SC and the epidermis that are accessible to ISF per unit of skin area. Note that these values are less than the total volumes of the corresponding tissues, respectively. With the assumption that V e available to the ISF corresponds to the cell free volume (ϳ10%), V SC ϩ V e is ϳ0.0005 cm 3 /cm 2 , corresponding to a thickness of 50 m between the epidermis and the SC (7, 16) . Because J ce is 0.018 cm/h (as predicted in Eq. 11), T is ϳ2 min. This time is less than the extraction time in our studies (5 min). Hence, this calculation supports our earlier assumption of the existence of steady state in our extraction experiments.
The extracted ISF was collected into a liquid reservoir with a volume of 1 ml; thus C cham is much less than C ISF . Because the model predicts the convective velocity of the ISF, it is now possible to predict the C cham of various analytes, in addition to glucose, using the following equation (20) where is the extraction time, A is the extraction area (cm 2 ), and V cham is the fluid volume (l) in which the extracted analytes are diluted. Our laboratory previously measured ISF and C cham of various analytes including glucose, urea, calcium, lactate, proteins, and triglycerides (12) . Figure 4 shows a comparison of the prediction of Eq. 20 (shown by solid line) (A ϭ 1.7 cm 2 and V cham ϭ 1,000 l, C SC ϭ C ISF , ϭ 0.25 h) with the experimental data taken from Ref. 12 . The predictions of the model compare favorably with the experimental data. Thus Eq. 20 can be used to predict C cham once the C ISF of a given analyte is known. Thus the results presented herein show that a short application of ultrasound increases skin P, so that ISF can be extracted through this skin at a rate of 25.6 l ⅐ cm Ϫ2 ⅐ h Ϫ1 . This rate is comparable with the theoretically predicted rate of 18 l ⅐ cm Ϫ2 ⅐ h Ϫ1 . Further work in this area should be focused on assessing the dynamic correlation between transdermally extracted f and blood levels of analytes other than glucose. Additional studies should also be performed to evaluate the safety of low-frequency sonophoresis and biosensor development.
